Exagen (XGN) said Monday it agreed to a term loan credit facility of up to $75 million with Perceptive Advisors.
Exagen said the first $25 million tranche was funded at close and used to retire its term debt facility with Innovatus Capital Partners.
The second and third tranches of $10 million each are available through Mar. 31, 2026, and Dec. 31, 2026, respectively, subject to achievement of certain revenue milestones, the company said.
The company added that a business development tranche of $30 million is available through Mar. 31, 2027, and will be funded at Perceptive's discretion.
Price: 6.31, Change: +0.10, Percent Change: +1.61
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。